Understanding the Real Cost of GLP-1 Medications Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications used to treat type 2 diabetes and promote weight loss
Against the backdrop of an expansive body of evidence indicating salutary cardiovascular effects of GLP-1 in the experimental animal model, there have been several phase 2 trials of GLP-1 in humans with cardiovascular diseases [5, 24, 30]
+Pre-treatment eye evaluation may be prudent in patients with known diabetic retinopathy or previous optic neuropathy
Body weight, first thing in the morning after using the bathroom, same scale every time
While appetite suppression remains a primary mechanism of action, the broader gutmetabolic interaction may represent an equally important therapeutic pathway
All medications offered through the Medicare GLP-1 Bridge require a valid prescription